Tocolysis with the β2-sympathomimetic fenoterol does not increase the occurrence of infantile hemangioma in preterm and term infants.

Hannes HudallaChristian KarmenThomas BrucknerStephanie WallwienerHerbert FluhrZoe MichaelAlexander FreisHolger MaulThomas StrowitzkiJohannes PöschlRuben-J Kuon

Published in: Archives of gynecology and obstetrics (2018)

Exposure to fenoterol during pregnancy does not increase the occurrence of IH. Further studies are needed to explore differences in the risk profiles of different β2-sympathomimetic tocolytic drugs.

Keyphrases

risk assessment
gestational age
preterm infants
low birth weight
preterm birth
case control